Analysts count on sales decrease Merck KGaA

For this year Merck KGaA KGaA's revenue will be around 14,72 billion euros. This is according to the average of the analysts' estimates. This is slightly lower than 2017's revenue of 15,33 billion euros.

Historical revenues and results Merck KGaA KGaA plus estimates 2018

fundamental data

The analysts expect for 2018 a net profit of 2,28 billion euros. According to most of the analysts the company will have a profit per share for this book year of 5,3 euros. The price/earnings-ratio is then 16,26.

For this year the analysts expect a dividend of 1,26 euros per share. Merck KGaA KGaA's dividend yield thus equals 1,46 percent. The average dividend yield of the pharmaceutical companies equals a limited 0,5 percent.

Latest estimates around 95 euros

Goldman Sachs , Independent Research and Berenberg recently provided recommendations for the stock.

Based on the current number of shares Merck KGaA KGaA's market capitalization equals 11,14 billion euros.

At 17.31 the stock trades 1,18 percent higher at 86,16 euros.

Historical stock prices Merck KGaA KGaA

fundamental data merckkgaa

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.